Wisplinghoff H, Seifert H, Coimbra M, Wenzel R P, Edmond M B
Institute of Medical Microbiology, Immunology, and Hygiene, University of Cologne, Cologne, Germany.
Clin Infect Dis. 2001 Sep 1;33(5):733-6. doi: 10.1086/322610. Epub 2001 Aug 6.
To determine the impact of methicillin resistance on clinical course and outcome, we evaluated nosocomial bloodstream infections (BSIs) due to Staphylococcus aureus that were diagnosed in 82 adult patients at the Medical College of Virginia Hospitals from December 1995 through May 1997. Patients with BSI due to methicillin-resistant S. aureus were compared with patients with BSI due to methicillin-susceptible S. aureus; the groups did not differ with regard to inflammatory response or outcome. Mortality was predicted by systemic inflammatory response and Acute Physiology and Chronic Health Evaluation II score but did not correlate with bacterial resistance to methicillin.
为确定耐甲氧西林特性对临床病程及结局的影响,我们评估了1995年12月至1997年5月间在弗吉尼亚医学院医院被诊断出的82例成年患者因金黄色葡萄球菌所致的医院血流感染(BSIs)。耐甲氧西林金黄色葡萄球菌所致血流感染患者与甲氧西林敏感金黄色葡萄球菌所致血流感染患者进行了比较;两组在炎症反应或结局方面无差异。全身炎症反应和急性生理与慢性健康状况评分II可预测死亡率,但死亡率与细菌对甲氧西林的耐药性无关。